Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
- Status
- COMPLETED
- Phase
- NA
An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study.
- Status
- WITHDRAWN
- Phase
- PHASE4
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China
- Status
- COMPLETED
- Phase
- PHASE1
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients
- Status
- COMPLETED
- Phase
- PHASE1
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts
- Status
- COMPLETED
- Phase
- NA
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
- Status
- COMPLETED
- Phase
- PHASE4
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Mail Outreach To Increase Vaccination Acceptance Through Engagement
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
- Status
- COMPLETED
- Phase
- PHASE3
Banlangen Granules Anti-seasonal Influenza Study
- Status
- UNKNOWN
- Phase
- PHASE4
Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4